China to Intensify its Management of Drug Prices
Published:
2010-05-26
The National Development and Reform Commission aims to curb the unreasonably high drug prices in China by intensifying its review and supervision of drug prices before they are sold to drug wholesalers and then hospitals. Experts said currently the cost price of drugs accounted for only 5% of their retail price.
Source
The Beijing News
The views posted here belong to the commentor, and are not representative of the Economic Observer |
Interactive
Multimedia
A look at Nanjing local government's controversial urban reconstruction project
E-paper
|
